Branched-chain amino acids-induced cardiac protection against ischemia/reperfusion injury
Life Sciences Volume 245
Page 117368-
published_at 2020-03-15
アクセス数 : 371 件
ダウンロード数 : 142 件
今月のアクセス数 : 8 件
今月のダウンロード数 : 8 件
この文献の参照には次のURLをご利用ください : https://ir.lib.hiroshima-u.ac.jp/00050462
File |
LifeSci_245_117368.pdf
874 KB
種類 :
fulltext
エンバーゴ :
2021-03-15
|
Title ( eng ) |
Branched-chain amino acids-induced cardiac protection against ischemia/reperfusion injury
|
Creator |
Satomi Shiho
Morio Atsushi
Miyoshi Hirotsugu
Tsutsumi Rie
Sakaue Hiroshi
|
Source Title |
Life Sciences
|
Volume | 245 |
Start Page | 117368 |
Abstract |
Aims: Amino acids, especially branched chain amino acids (BCAAs), have important regulatory roles in protein synthesis. Recently studies revealed that BCAAs protect against ischemia/reperfusion (I/R) injury. We studied the signaling pathway and mitochondrial function affecting a cardiac preconditioning of BCAAs.
Main methods: An in vivo model of I/R injury was tested in control, mTOR+/+, and mTOR+/−. Mice were randomly assigned to receive BCAAs, rapamycin, or BCAAs + rapamycin. Furthermore, isolated cardiomyocytes were subjected to simulated ischemia and cell death was quantified. Biochemical and mitochondrial swelling assays were also performed. Key findings: Mice treated with BCAAs had a significant reduction in infarct size as a percentage of the area at risk compared to controls (34.1 ± 3.9% vs. 44.7 ± 2.6%, P = 0.001), whereas mice treated with the mTOR inhibitor rapamycin were not protected by BCAA administration (42.2 ± 6.5%, vs. control, P = 0.015). This protection was not detected in our hetero knockout mice of mTOR. Western blot analysis revealed no change in AKT signaling whereas activation of mTOR was identified. Furthermore, BCAAs prevented swelling which was reversed by the addition of rapamycin. In myocytes undergoing simulated I/R, BCAA treatment significantly preserved cell viability (71.7 ± 2.7% vs. 34.5 ± 1.6%, respectively, p < 0.0001), whereas rapamycin prevented this BCAA-induced cardioprotective effect (43.5 ± 3.4% vs. BCAA, p < 0.0001). Significance: BCAA treatment exhibits a protective effect in myocardial I/R injury and that mTOR plays an important role in this preconditioning effect. |
Keywords |
Amino acid
Ischemia
Reperfusion
mTOR
Mitochondria
|
Descriptions |
This work was supported by JSPS KAKENHI, Japan [grant number 19K09353].
|
Language |
eng
|
Resource Type | journal article |
Publisher |
Elsevier
|
Date of Issued | 2020-03-15 |
Rights |
© 2020. This manuscript version is made available under the CC-BY-NC-ND 4.0 license http://creativecommons.org/licenses/by-nc-nd/4.0/
This is not the published version. Please cite only the published version. この論文は出版社版ではありません。引用の際には出版社版をご確認、ご利用ください。
|
Publish Type | Author’s Original |
Access Rights | open access |
Source Identifier |
[ISSN] 0024-3205
[DOI] 10.1016/j.lfs.2020.117368
[PMID] 32001270
[DOI] https://doi.org/10.1016/j.lfs.2020.117368
|
Remark | Post-print version/PDF may be used in an institutional repository after an embargo period of 12 months. |